Posted inComunicati
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE Financing supports the approval of U.S. Investigational Device Exemption (IDE),…







